Study guide

10.2 Benign Breast Diseases & Breast Carcinoma

Combined Medical Services Examination UPSC CMS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Logistics & Pattern

1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths

2 Chapter 2: General Medicine - Cardiology & Respiratory

2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism

3 Chapter 3: General Medicine - Gastroenterology & Hepatology

3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes

4 Chapter 4: General Medicine - Nephrology & Endocrinology

4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction

5 Chapter 5: General Medicine - Neurology, Haematology & Infection

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue

6 Chapter 6: General Medicine - Emergency Medicine & Toxicology

6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology

7 Chapter 7: Paediatrics - Neonatology & Child Growth

7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones

8 Chapter 8: Paediatrics - Child Health & Nutrition

8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning

9 Chapter 9: Surgery - General Surgery, Wounds & Shock

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery

10 Chapter 10: Surgery - Surgical Specialties I

10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi

11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia

11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease

12 Chapter 12: Obstetrics - Antenatal Care & Complications

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management

13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH

13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care

14 Chapter 14: Gynaecology & Family Planning

14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods

15 Chapter 15: PSM - Epidemiology & Biostatistics

15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing

16 Chapter 16: PSM - Disease Epidemiology & Programmes

16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling

17 Chapter 17: PSM - Health Planning & Environmental Health

17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education

10.2 Benign Breast Diseases & Breast Carcinoma

Key Takeaways Explain This Topic AI

Fibroadenoma ('breast mouse') is the most common benign breast tumor in young women (<30 years), characterized by a firm, smooth, highly mobile, painless mass.

Triple Assessment for any suspicious breast lump consists of: 1) Clinical examination, 2) Imaging (ultrasound for <35 years, bilateral diagnostic mammography for ≥35 years), and 3) Histopathology (core needle biopsy).

Invasive Ductal Carcinoma (NST) is the most common histological type of breast cancer (~75-80%); pleomorphic clustered microcalcifications on mammography are pathognomonic early signs.

Molecular subtypes (Luminal A, Luminal B, HER2-enriched, Triple Negative) guide prognosis and systemic therapy, with Triple Negative carcinomas having the highest rate of early visceral recurrence.

Surgical resection options include Breast Conservation Therapy (BCT: wide local excision + RT + sentinel node biopsy) and Modified Radical Mastectomy (MRM), with careful preservation of the long thoracic and thoracodorsal nerves.

Last updated: July 2026

Benign Breast Diseases & Breast Carcinoma

Breast pathology ranges from benign developmental aberrations (ANDI - Aberrations of Normal Development and Involution) to life-threatening invasive carcinomas. A solid understanding of clinical presentation, diagnostic algorithms, staging, and surgical techniques is vital for UPSC CMS aspirants.

  • 1. Benign Breast Conditions
  • Fibroadenoma

Demographics : Most common benign breast tumor in young women aged 15-30 years.

Pathology : Benign biphasic tumor consisting of epithelial and stromal elements. Histologically exhibits pericanalicular or intracanalicular growth patterns.

Clinical Features : Painless, firm, smooth, rubbery, well-circumscribed mass. Highly mobile within breast tissue, earning the classical sobriquet "breast mouse" .

Giant Fibroadenoma : Defined as fibroadenoma >5 cm in size or >500 grams in weight.

Management : Reassurance and observation for small (<2 cm) lesions in young women (<25 yrs). Surgical excision indicated if >3 cm, rapidly growing, painful, or patient >35 years.

Fibrocystic Disease (Mammary Dysplasia)

Etiology : Aberrant response of breast tissue to cyclical ovarian hormonal stimulation (estrogen excess / progesterone deficiency).

Clinical Features : Cyclical mastalgia (worse premenstrually) and painful bilateral, diffuse, lumpy breast nodularity.

Histology : Cysts, apocrine metaplasia, sclerosing adenosis, and ductal epithelial hyperplasia. Epithelial hyperplasia with atypia carries a 4-5x increased risk of breast cancer.

Phyllodes Tumor (Cystosarcoma Phyllodes)

Pathology : Biphasic tumor with hypercellular stromal proliferation showing characteristic leaf-like projections under microscopy. Classified as Benign (70%), Borderline (15%), or Malignant (15%).

Clinical Features : Fast-growing, large, bosselated breast mass in women aged 40-50 years. Overlying skin is shiny, stretched, with dilated superficial veins, but non-adherent to skin/chest wall.

Management : Wide local excision with a 1 cm clear margin . Axillary lymph node dissection is NOT required because phyllodes tumors spread via the hematogenous route (metastasis to lungs/bones) rather than lymphatics.

Intraductal Papilloma

Clinical Presentation : Most common cause of spontaneous bloody or serosanguinous single-duct nipple discharge .

Location : Typically subareolar in major lactiferous ducts.

Management : Microdochectomy (excision of single affected duct - Urban procedure) or Hadfield's operation (total duct excision).

Fat Necrosis

Etiology : Follows direct breast trauma, prior surgery, or radiotherapy.

Clinical Significance : Mimics breast carcinoma both clinically (hard, irregular, fixed mass with skin tethering) and radiologically. Biopsy is essential and reveals lipid-laden foam cells, multinucleated giant cells, and cholesterol clefts.

2. Triple Assessment & Mammography

Any patient presenting with a discrete breast lump must undergo the Triple Assessment to achieve 99.9% diagnostic accuracy:

Clinical Examination : History, bilateral breast inspection, palpation, and regional lymph node evaluation.

Diagnostic Imaging :

Ultrasound (USG) : Modality of choice in women <35 years (dense fibroglandular parenchyma). Excellent for differentiating fluid-filled cysts from solid masses.

Mammography : Modality of choice in women ≥35 years . Standard views: Craniocaudal (CC) and Mediolateral Oblique (MLO). Malignant features include irregular spicated masses, architectural distortion, and pleomorphic microcalcifications clustered (>5 per cm³).

BI-RADS Classification : BIRADS 1 (Normal), BIRADS 2 (Benign), BIRADS 3 (Probably benign, <2% risk, follow-up in 6 mo), BIRADS 4 (Suspicious, biopsy recommended), BIRADS 5 (Highly suggestive of malignancy, >95% risk), BIRADS 6 (Known biopsy-proven malignancy).

Histopathological Confirmation :

Core Needle Biopsy (CNB) : Gold Standard . Uses a 14-gauge automated tru-cut needle. Provides tissue architecture to distinguish invasive from in situ carcinoma and permits ER, PR, HER2 receptor testing.

FNAC : Cytological assessment only; cannot distinguish invasive ductal carcinoma from DCIS.

3. Histological Types & Molecular Subtypes of Breast Carcinoma

Invasive Ductal Carcinoma - Not Otherwise Specified (IDC-NOS) : Accounts for 75-80% of all breast cancers.

Invasive Lobular Carcinoma (ILC) : Accounts for 10-15%. Characterized by loss of E-cadherin expression. Frequently bilateral and multicentric. Shows an 'Indian file' pattern of single cells invading stroma.

Molecular Subtypes Table

Subtype Hormone Receptors (ER/PR) HER2 Receptor Ki-67 Proliferation Index Prognosis & Key Therapy

Luminal A ER+ and/or PR+ HER2 negative Low (<20%) Best prognosis ; highly responsive to endocrine therapy (Tamoxifen / Letrozole).

Luminal B ER+ and/or PR+ HER2 +/- High (≥20%) Intermediate prognosis; requires endocrine therapy + chemotherapy +/- Trastuzumab.

HER2-Enriched ER- and PR- HER2 positive Variable Aggressive; highly responsive to anti-HER2 targeted therapy ( Trastuzumab / Pertuzumab ).

Triple Negative (TNBC) ER-, PR- HER2 negative High Worst prognosis ; frequent BRCA1 mutations; prone to early lung/brain metastases; chemotherapy main stay.

  • 4. TNM Staging & Surgical Management
  • TNM Clinical Staging Highlights

T1 : Tumor ≤ 2 cm in greatest dimension.

T2 : Tumor > 2 cm but ≤ 5 cm.

T3 : Tumor > 5 cm.

T4 : T4a (chest wall fixation), T4b (skin involvement: ulceration, peau d'orange [dermal lymphatic embolization], skin nodules), T4c (both T4a and T4b), T4d ( Inflammatory Breast Cancer - diffuse erythema, edema covering >1/3 of breast).

N1 : Mobile ipsilateral Level I/II axillary lymph nodes.

N2 : Fixed/matted ipsilateral axillary nodes.

N3 : Ipsilateral infraclavicular (Level III), internal mammary, or supraclavicular nodes.

Surgical Operations

Breast Conservation Therapy (BCT) :

Components : Wide Local Excision (WLE with 1 cm clear margin) + Sentinel Lymph Node Biopsy (SLNB) / Axillary Lymph Node Dissection (ALND) + Whole Breast Postoperative Radiotherapy .

Absolute Contraindications : Multicentric disease (tumors in different quadrants), widespread malignant microcalcifications, prior chest wall radiation, persistent positive surgical margins after re-excision, pregnancy in 1st/2nd trimester.

Modified Radical Mastectomy (MRM) :

Auchincloss Procedure : Removes total breast tissue, nipple-areola complex, skin, pectoralis major fascia, and Level I & II axillary lymph nodes. Preserves pectoralis minor .

Patey Procedure : Includes division or excision of pectoralis minor to access Level III axillary nodes.

Axillary Dissection & Nerves at Risk

Level I Nodes : Lateral to lateral border of pectoralis minor.

Level II Nodes : Deep to pectoralis minor.

Level III Nodes : Medial to medial border of pectoralis minor.

Nerves to Preserve :

Long Thoracic Nerve of Bell : Arises from C5, C6, C7; runs along lateral thoracic wall to supply Serratus Anterior . Injury leads to winged scapula (inability to push against a wall or abduct arm above 90°).

Thoracodorsal Nerve : Supplies Latissimus Dorsi . Injury causes loss of extension, adduction, and internal rotation of the shoulder.

Intercostobrachial Nerve : Sensory nerve crossing axilla; transection causes numbness over the upper medial arm.

Loading diagram... Clinical Diagnostic & Surgical Workflow for Breast Mass